RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
Congratulations. Sounds very promising @AnnSurgOncol
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
RT SocSurgOnc RT AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in #BreastCancer. https://t.co/S5hDwoYu1z McMastersKelly SocSurgOnc https://t.co/PKsipdk4Ua
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
RT @AnnSurgOncol: DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Progno…
DECEMBER ISSUE: Novel #MicroRNA -Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in #BreastCancer. https://t.co/eKMYgK3m52 @McMastersKelly @SocSurgOnc https://t.co/igD856PeZH
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. https://t.co/7Jrr1ZbQiG